News | July 28, 2022
Biocon Q1FY23 consolidated PAT falls QoQ at Rs. 144.4 Cr
Biocon has reported total income of Rs. 2217.4 crores during the period ended June 30, 2022.
Biocon has reported total income of Rs. 2217.4 crores during the period ended June 30, 2022.
Novartis India has reported total income of Rs. 147.44 crores during the period ended June 30, 2022.
Dr. Lal Path Labs has reported total income of Rs. 511 crores during the period ended June 30, 2022
This will not only strengthen the country’s overall position in the global vaccine industry but also reduce its reliance on foreign vaccines
Aarti Drugs Limited has reported total income of Rs. 622.22 crores during the quarter ended June 30, 2022.
The company has reported total income of Rs. 186.97 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 94.30 crores during the period ended June 30, 2022.
GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022
The product will be manufactured at Lupin's facility in Nagpur, India.
Suven Life Sciences has reported total income of Rs. 3.97 crores during the period ended June 30, 2022
Subscribe To Our Newsletter & Stay Updated
